Cell-Killing Protein Offers Hope for Defeating Cancer, Diabetes
By wchung | 07 May, 2026
A team of Australian scientists published their findings on the workings of a protein that kills cells in Monday’s issue of the journal Nature. Their work raises hope of developing drugs that can zero in on cells that cause cancer and other immune system disorders.
The protein perforin has been revealed to be the body’s defense against rogue cells that have become cancerous or hijacked by viruses by punching holes into the cells to allow toxic enzymes to invade and destroy them. This work is deemed a major advance in the field of immunology. By uncovering the precise mechanism of perforin, researchers will be able to focus their efforts on more effective and targeted ways to defeat diseases like cancer and malaria, and even disorders like diabetes.
The findings are the fruits of 10 years of collaboration between a team headed by Professor James Whisstock, an Australian Research Council Federation fellow at Monash University, a second Australian team at the Peter McCallum Cancer Institute in Melbourne, and scientists at Birkbeck College in London of Britain.
CANBERRA
Recent Articles
- Asian Stocks Hit Record High, Dollar Wobbles on Peace Hopes
- Latest Trump Peace Proposal to Iran Omits Key Terms in Bid for Quick Peace
- New York Judge Releases Purported Epstein Suicide Note
- My Favorite Asian Looks at the 2026 Met Gala
- Anthropic to Use SpaceX Data Center As Personality Clash Fades
- UCLA Med School Accused by DOJ of Favoring Black, Hispanic Applicants
- Weekly Sports Roundup: Clutch Plays from Suzuki and Hachimura, Ji KO’s Bully
- Top Quantum Computing Advances of April 2026
- Correspondents Dinner Shooter May Have Been Triggered by Iran
- Rivian Developing Variants of Affordable R2 EVs
